Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market
Holding NMRA?
Track your performance easily

Neumora Therapeutics, Inc. (NMRA) Cash flow

135 Followers

Neumora Therapeutics, Inc. Cash Flow

NMRA's free cash flow for Q2 2024 was £-56.16M. For the 2024 fiscal year, NMRA's free cash flow was decreased by £-34.99M and operating cash flow was £-56.16M. See a summary of the company’s cash flow.
Cash Flow
TTM
Dec 23Dec 22
Operating Cash Flow
£ -146.89M£ -163.28M£ -114.90M
Investing Cash Flow
£ -104.93M£ 64.39M£ -168.01M
Financing Cash Flow
£ 236.52M£ 231.94M£ 115.74M
Cash Flow From Discontinued Operation
---
Other Cash Adjustment Inside Changein Cash
---
End Cash Position
£ 336.03M£ 374.04M£ 242.21M
Income Tax Paid Supplemental Data
---
Interest Paid Supplemental Data
---
Issuance Of Capital Stock
£ 810.00K£ 233.38M£ 112.22M
Issuance Of Debt
---
Repayment Of Debt
---
Free Cash Flow
£ -146.92M£ -163.40M£ -128.41M
Domestic Sales
---
Foreign Sales
---
Currency in GBP

Neumora Therapeutics, Inc. Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis